Non-specific

Question 1

vaccine for the prevention of herpes zoster (shingles) infection for
immunocompetent patients age 50 and older?

Answer 1

recombinant zoster vaccine in 2 doses
administered 2–6 months apart

Question 2

The relative risk (risk ratio) calculated by dividing the risk of the population under study by the risk of the population who is not
(those who are vaccinated and those who are not, respectively): 0.19/0.47 = 0.40